NCT06457503
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06457503
Title A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal Cancer (TRANSPARENT)
Acronym TRANSPARENT
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors Coherus Oncology, Inc.
Indications
Therapies
Age Groups: senior | adult | child
Covered Countries USA | CAN

Facility Status City State Zip Country Details
University of Arkansas for Medical Sciences RECRUITING Little Rock Arkansas 72205 United States Details
University of California, Irvine RECRUITING Irvine California 92697 United States Details
University of California, San Francisco RECRUITING San Francisco California 94115 United States Details
Emory Winship Cancer Institute RECRUITING Atlanta Georgia 30322 United States Details
Boston Medical Center RECRUITING Boston Massachusetts 02118 United States Details
University of Michigan RECRUITING Ann Arbor Michigan 48109 United States Details
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health RECRUITING New York New York 10016 United States Details
University of Cincinnati Medical Center RECRUITING Cincinnati Ohio 45219 United States Details
Cleveland Clinic RECRUITING Cleveland Ohio 44195 United States Details
Froedtert Hospital and the Medical College of Wisconsin RECRUITING Milwaukee Wisconsin 53226 United States Details
Princess Margaret Cancer Centre RECRUITING Toronto MSG 1Z5 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field